Testing Tactile Aids With Blind Subjects
Launched by UNIVERSITY OF DELAWARE · Jan 31, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring new types of tactile aids designed for people who are blind or have low vision. The goal is to improve the way these aids feel, making it easier for users to identify different objects. Instead of just using simple bumps and textures, the researchers are trying out special materials that can create more interesting and varied sensations. This study will measure how accurately participants can recognize objects and how quickly they can complete tasks with these new aids compared to traditional ones.
To participate, individuals must have been blind or visually impaired for more than 10 years and should regularly use tactile aids. A basic understanding of shapes and graphs, similar to high school geometry, is also required. However, people with conditions that affect their hand use will not be eligible. If you join the trial, you can expect to work with new tactile materials and contribute to research that could help improve daily living for those with visual impairments. The trial is currently looking for participants of all ages who meet the criteria.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Visual Impairment: Participants should be blind or visually impaired for greater than 10 years, either congenitally or acquired.
- • Tactile Aid Usage: Participants must use tactile aids regularly.
- • Mathematical Knowledge: Participants should have a basic understanding of mathematical plots, equivalent to at least high school geometry.
- Exclusion Criteria:
- • - Limb Conditions: Participants with amputations or outer extremity conditions affecting hand use will be excluded.
About University Of Delaware
The University of Delaware, a renowned research institution, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its expertise in various fields, including health sciences, engineering, and behavioral health, to conduct rigorous and ethical research. The university's commitment to scientific excellence and community engagement ensures that its clinical trials not only contribute to groundbreaking discoveries but also prioritize participant safety and well-being. Through its state-of-the-art facilities and a team of experienced researchers, the University of Delaware is positioned to make significant contributions to the field of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Newark, Delaware, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported